- 产品名称
- 依曲韦林
- CAS NO
- 269055-15-4
- 中文别名
- 4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈
- 英文名称
- Benzonitrile,4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-
- 英文别名
- Etravirine;Intelence; R 165335; TMC 125
- 分子式
- C20H15BrN6O
- 分子量
- 0
- EINECS
- 682-331-6
- 熔点
- 265oC (dec.)
- 沸点
- 637.4oC at 760mmHg
- 毒性
依曲韦林269055-15-4;4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈
436133-68-5
|
1011301-27-1
|
1011557-82-6
|
312756-74-4
|
178946-89-9
|
24144-92-1
|
168425-64-7
|
728865-23-4
|
851983-85-2
|
1429881-91-3
|
该产品相关资料:
中文名称:
|
4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈
|
中文同义词:
|
4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈;依曲韦林;依曲韦林;依曲韦林-D6;依曲韦林合成工艺
|
英文名称:
|
4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5 –dimethylbenzonitrile
|
英文同义词:
|
4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5 –dimethylbenzonitrile;Etravirine;Etravirine(TMC-125);R 165335;TMC 125;4-(6-amino-5-bromo-2-(4-cyanobenzyl)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile, Etravirine;4-[[6-AMino-5-broMo-2-[(4-cyanophenyl)aMino]-4-pyriMidinyl]oxy]-3,5-diMethyl -;4-[[6-aMino-5-broMo-2-[(4-cyanophenyl)aMino]-4-pyriMidinyl]oxy]-3, 5 –diMethylbenzonitrile/Etravirine
|
CAS号:
|
269055-15-4
|
分子式:
|
C20H15BrN6O
|
分子量:
|
435.284
|
EINECS号:
|
1592732-453-0
|
相关类别:
|
新型抗HIV药;原料药;信号转导通路激酶抑制剂;杂环类;原料药中间体;小分子抑制剂;小分子抑制剂,天然产物;有机原料;微生物Microbiology;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Non-nucleoside Reverse Transcriptase
|
Mol文件:
|
269055-15-4.mol
|
4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈 性质
|
熔点
|
.265°C (dec.)
|
储存条件
|
-20°C Freezer
|
|
4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈 用途与合成方法
|
生物活性
|
Etravirine (TMC125)是一种非核苷类逆转录酶抑制剂(NNRTI),用于治疗HIV。
|
体外研究
|
Etravirine (TMC125), is highly active against wild-type HIV-1 with EC50 of 1.4 nM to 4.8 nM shows some activity against HIV-2 with EC50 of 3.5 μM. TMC125 also inhibits a series of HIV-1 group M subtypes circulating recombinant forms a group O virus.
|
体内研究
|
Etravirine has a high genetic barrier to the development of resistance. In phase IIb trials in treatment-experienced patients, including those infected with virus resistant to NNRTIs protease inhibitors (PIs), TMC125 is active against HIV resistant to currently available NNRTIs, with a similar tolerability profile to that of the control group.
|
结构式:
我公司其他相关部分产品列表:
利拉利汀
Linagliptin
|
富马酸沃诺拉赞(TAK-438, Vonoprazan
fumarate)
|
奥贝胆酸
Obeticholic Acid
|
阿伐那非
Avanafil
|
AZD9291(甲磺酸盐)
Mesylate
|
LCZ696 诺华心衰药ENTRESTO
|
MK-2206 2HCl
一种变构 AKT 抑制剂
|
依曲韦林
4-[[2-[(4-氰基苯基)氨基]-5-溴-6-氨基]-4-嘧啶基氧基]-3,5-二甲基苯腈
|
(1R,3R)-1-(1,3-苯并二氧戊环-5-基)-2-(氯乙酰基)-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-3-羧酸甲酯
|
温馨提示:仅用于科研哦,不能用于人体治疗、药物开发和其他商业用途my2018.11.28